Compartment Syndrome Traumatic Lower Extremity
1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Oregon TherapeuticsFrance - Paris
1 program1
Intramuscular administration of autologous BM-MNCsPhase 11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Oregon TherapeuticsIntramuscular administration of autologous BM-MNCs
MY01MY01 Continuous Compartmental Pressure Monitor
Clinical Trials (2)
Total enrollment: 118 patients across 2 trials
BM-MNCs for Lower Extremity Compartment Syndrome Injury
Start: Dec 2019Est. completion: Jun 202618 patients
Phase 1Active Not Recruiting
Clinical Trial of a New Device for Real-Time Muscle Pressure Measurements in Patients at Risk for Acute Compartment Syndrome
Start: Nov 2020Est. completion: Mar 2023100 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.